Compound class:
Synthetic organic
Comment: Compound 58l is a derivative of the P2Y12 receptor antagonist AZD1283 that has been optimised for drug-like properties (e.g. enhanced metabolic stability and antithrombotic efficacy in vivo) [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 58l potently inhibits platelet aggregation in vitro, and exhibits effective antithrombotic efficacy in vivo [1]. Compound 58l inhibits CYP2 family P450 enzymes with higher IC50s (i.e. less effectively) than AZD1283, and is significantly more stable in microsomal stability assays than AZD1283. |
Selectivity at GPCRs | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|